Cargando…
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017()
Recent research on genomic profiling of pancreatic ductal adenocarcinoma (PDAC) has identified many potentially actionable alterations. However, the feasibility of using genomic profiling to guide routine clinical decision making for PDAC patients remains unclear. We retrospectively reviewed PDAC pa...
Ejemplares similares
-
The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience
por: Javed, Ammar A., et al.
Publicado: (2022) -
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer
por: Gemenetzis, Georgios, et al.
Publicado: (2021) -
Mesothelin-specific CD8(+) T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
por: Thomas, Amy Morck, et al.
Publicado: (2004) -
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022) -
Insights into the endoscopic management of esophageal achalasia
por: Brindise, Elizabeth, et al.
Publicado: (2021)